Abstract
Xanthohumol (XN) is a prenylated chalcone found at high concentrations in hop cones (Humulus lupulus L.). XN has been characterized as a promising cancer chemopreventive lead structure that acts via a broad spectrum of bioactivities. This chapter summarizes the anti-proliferative and apoptosis-inducing potential of XN and gives a detailed overview of underlying mechanisms and pathways targeted by XN to induced programmed cell death. XN is a potent inhibitor of NF-κB and inhibits activation of the death-receptor pathway by tumor necrosis factor (TNF). In various cell lines, XN treatment results in an immediate transient increase in mitochondria-derived reactive oxygen species (ROS) that is considered as the initial trigger of apoptosis induction via the intrinsic pathway by breakdown of the mitochondrial membrane potential, release of cytochrome c and activation of the caspase cascade. Oxidative stress may also contribute to the activation of endoplasmatic reticulum (ER) stress and unfolded protein response recently identified as a novel mechanisms underlying XN-mediated apoptosis induction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AML:
-
acute myelocytic leukemia
- A-SMase:
-
acid sphingomyelinase
- ATF:
-
activating transcription factor
- ATP:
-
adenosine triphosphate
- BiP:
-
immunoglobulin-heavy-chain binding protein
- BPH:
-
benign prostate hyperplasia
- CHOP:
-
CAAT/enhancer-binding protein (C/EBP) homologous protein
- CLL:
-
chronic lymphocytic leukemia
- Cox:
-
cyclooxygenase
- CYP:
-
cytochrome P450
- DC:
-
dendritic cells
- DCF-DA:
-
dichlorofluorescein-diacetate
- DHE:
-
dihydroethidium
- DISC:
-
death-inducing signaling complex
- DMBA:
-
dimethylbenz-[a]-anthracene
- DMSO:
-
dimethylsulfoxide
- DR:
-
death receptor
- ER:
-
endoplasmatic reticulum
- FADD:
-
Fas-associated death domain
- FITC:
-
fluorescein isothiocyanate
- Gadd153:
-
growth arrest and DNA damage 153
- GRP78:
-
glucose-regulated protein 78
- GSH:
-
glutathione
- H2O2 :
-
hydrogen peroxide
- HUVEC:
-
human umbilical vein endothelial cells
- IC50 :
-
half-maximal inhibitory concentration
- IKK:
-
I-κB kinase
- IL:
-
interleukin
- Ire1α:
-
inositol-requiring 1α
- LDH:
-
lactate dehydrogenase
- MMP:
-
matrix metalloprotease
- MnTMPyP:
-
manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin
- MTT:
-
3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazoliumbromide
- NAC:
-
N-acetyl cysteine
- NAD(P)H:
-
nicotinamide adenine dinucleotide phosphate
- NF-κB:
-
nuclear factor κB
- O -•2 :
-
superoxide anion radicals
- OH• :
-
hydroxyl radicals
- PARP:
-
poly(ADP-ribose)polymerase
- PERK:
-
double stranded RNA-dependent protein kinase (PKR)-like ER kinase
- RIP:
-
receptor interacting kinase
- ROS:
-
reactive oxygen species
- SCID:
-
severe combined immuno-deficient
- SM:
-
sphingomyelin
- SOD:
-
superoxide dismutase
- SRB:
-
sulforhodamine B
- TNF:
-
tumor necrosis factor
- TNF-R1:
-
TNF-receptor 1
- TRAF:
-
TNF receptor-associated factor
- TRAIL:
-
TNF-related apoptosis-inducing ligand
- Trb3:
-
Tribble homolog 3
- TUNEL:
-
TdT-mediated dUTP-biotin nick end labeling
- UPR:
-
unfolded protein response
- XBP1:
-
X-box-binding protein 1
- XN:
-
Xanthohumol
- Ψm :
-
mitochondrial membrane potential
- ρ0 :
-
rho zero
References
Ak P, Levine AJ (2010) p53 and NF-kappaB: different strategies for responding to stress lead to a functional antagonism. FASEB J 24(10):3643–3652. doi:fj.10-160549 [pii] 10.1096/fj.10-160549
Albini A, Dell’Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, Fassina G (2006) Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J 20(3):527–529
Botta B, Vitali A, Menendez P, Misiti D, Delle MG (2005) Prenylated flavonoids: pharmacology and biotechnology. Curr Med Chem 12(6):717–739
Boveris A, Cadenas E (1975) Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration. FEBS Lett 54(3):311–314
Boveris A, Chance B (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134(3):707–716
Carpinteiro A, Dumitru C, Schenck M, Gulbins E (2008) Ceramide-induced cell death in malignant cells. Cancer Lett 264(1):1–10. doi: S0304-3835(08)00082-7 [pii] 10.1016/j.canlet.2008.02.020
Chadwick LR, Pauli GF, Farnsworth NR (2006) The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine 13(1-2):119–131
Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246(1–2):201–209
Dell’Eva R, Ambrosini C, Vannini N, Piaggio G, Albini A, Ferrari N (2007) AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer 110(9):2007–2011
Delmulle L, Vanden Berghe T, Keukeleire DD, Vandenabeele P (2008) Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death. Phytother Res 22(2):197–203. doi:10.1002/ptr.2286
Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10(9):369–377
Dorn C, Kraus B, Motyl M, Weiss TS, Gehrig M, Scholmerich J, Heilmann J, Hellerbrand C (2010a) Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Mol Nutr Food Res 54(Suppl 2):S205–213. doi:10.1002/mnfr.200900314
Dorn C, Weiss TS, Heilmann J, Hellerbrand C (2010b) Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. Int J Oncol 36(2):435–441
Faitova J, Krekac D, Hrstka R, Vojtesek B (2006) Endoplasmic reticulum stress and apoptosis. Cell Mol Biol Lett 11(4):488–505. doi:10.2478/s11658-006-0040-4
Fruehauf JP, Meyskens FL Jr (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13(3):789–794
Gao X, Deeb D, Liu Y, Gautam S, Dulchavsky SA, Gautam SC (2009) Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB. Immunopharmacol Immunotoxicol 31(3):477–484. doi:10.1080/08923970902798132
Gerhauser C (2005) Beer constituents as potential cancer chemopreventive agents. Eur J Cancer 41(13):1941–1954
Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf HR, Frank N, Bartsch H, Becker H (2002) Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol Cancer Ther 1(11):959–969
Goto K, Asai T, Hara S, Namatame I, Tomoda H, Ikemoto M, Oku N (2005) Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Lett 219(2):215–222. doi: S0304-3835(04)00577-4 [pii] 10.1016/j.canlet.2004.07.034
Grassme H, Cremesti A, Kolesnick R, Gulbins E (2003) Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22(35):5457–5470. doi: 10.1038/sj.onc.1206540 1206540 [pii]
Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281(5381):1309–1312
Guerreiro S, Monteiro R, Martins MJ, Calhau C, Azevedo I, Soares R (2007) Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells. Clin Biochem 40(3–4):268–273
Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142(2):231–255
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Harikumar KB, Kunnumakkara AB, Ahn KS, Anand P, Krishnan S, Guha S, Aggarwal BB (2009) Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 113(9):2003–2013
Heath-Engel HM, Chang NC, Shore GC (2008) The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene 27(50):6419–6433. doi: onc2008309 [pii] 10.1038/onc.2008.309
Henderson MC, Miranda CL, Stevens JF, Deinzer ML, Buhler DR (2000) In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30(3):235–251
Ho YC, Liu CH, Chen CN, Duan KJ, Lin MT (2008) Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines. Phytother Res 22(11):1465–1468. doi:10.1002/ptr.2481
Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4(2):139–163. doi: 1508 [pii]
Kamata H, Hirata H (1999) Redox regulation of cellular signalling. Cell Signal 11(1):1–14
Klenke E (2008) Inhibition of angiogenesis by potential chemopreventive agents, vol 1. Vdm Verlag Dr Müller, Saarbrücken
Lee SH, Kim HJ, Lee JS, Lee IS, Kang BY (2007) Inhibition of topoisomerase I activity and efflux drug transporters’ expression by xanthohumol. from hops. Arch Pharm Res 30(11):1435–1439
Lust S, Vanhoecke B, Janssens A, Philippe J, Bracke M, Offner F (2005) Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanism. Mol Nutr Food Res 49(9):844–850. doi:10.1002/mnfr.200500045
Lust S, Vanhoecke B, Van GM, Boelens J, Van MH, Kaileh M, Vanden Berghe W, Haegeman G, Philippe J, Bracke M, Offner F (2009) Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia. Anticancer Res 29(10):3797–3805
Magalhaes PJ, Carvalho DO, Cruz JM, Guido LF, Barros AA (2009) Fundamentals and health benefits of xanthohumol, a natural product derived from hops and beer. Nat Prod Commun 4(5):591–610
Malhotra JD, Kaufman RJ (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9(12):2277–2293. doi:10.1089/ars.2007.1782
Mendes V, Monteiro R, Pestana D, Teixeira D, Calhau C, Azevedo I (2008) Xanthohumol influences preadipocyte differentiation: implication of antiproliferative and apoptotic effects. J Agric Food Chem 56(24):11631–11637. doi: 10.1021/jf802233q10.1021/jf802233q [pii]
Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH, Deinzer ML, Barnes DW, Buhler DR (1999) Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol 37(4):271–285. doi: S0278691599000198 [pii]
Miranda CL, Aponso GL, Stevens JF, Deinzer ML, Buhler DR (2000a) Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Lett 149(1–2):21–29
Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, Buhler DR (2000b) Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem 48(9):3876–3884. doi:10.1021/Jf0002995
Monteghirfo S, Tosetti F, Ambrosini C, Stigliani S, Pozzi S, Frassoni F, Fassina G, Soverini S, Albini A, Ferrari N (2008) Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Mol Cancer Ther 7(9):2692–2702
Monteiro R, Becker H, Azevedo I, Calhau C (2006) Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J Agric Food Chem 54(8):2938–2943
Monteiro R, Faria A, Azevedo I, Calhau C (2007) Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol 105(1–5):124–130. doi: S0960-0760(07)00105-7 [pii] 10.1016/j.jsbmb.2006.11.026
Monteiro R, Calhau C, Silva AO, Pinheiro-Silva S, Guerreiro S, Gartner F, Azevedo I, Soares R (2008) Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J Cell Biochem 104(5):1699–1707
Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143–183
Pan L, Becker H, Gerhauser C (2005) Xanthohumol induces apoptosis in cultured 40–16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol Nutr Food Res 49(9):837–843
Pani G, Koch OR, Galeotti T (2009) The p53-p66shc-Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. Int J Biochem Cell Biol 41(5):1002–1005
Rayalam S, Yang JY, Della-Fera MA, Park HJ, Ambati S, Baile CA (2009) Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes. J Med Food 12(4):846–853. doi:10.1089/jmf.2008.0158
Simon HU, Haj-Yehia A, Levi-Schaffer F (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5(5):415–418
Stevens JF, Page JE (2004) Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 65(10):1317–1330
Stevens JF, Ivancic M, Hsu VL, Deinzer ML (1997) Prenylflavonoids from Humulus lupulus. Phytochemistry 44(8):1575–1585
Strathmann J, Klimo K, Steinle R, Hussong R, Frank N, Gerhauser C (2009) Xanthohumol from Hops Prevents Hormone-dependent Tumorigenesis in vitro and in vivo. Acta Hortic. Proceedings of the second international humulus symposium 848:179–190
Strathmann J, Klimo K, Sauer SW, Okun JG, Prehn JHM, Gerhauser C (2010) Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism. FASEB J 24(8):2938–2950. doi:10.1096/fj.10-155846
Szliszka E, Czuba ZP, Mazur B, Paradysz A, Krol W (2010) Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 15(8):5336–5353. doi: molecules15085336 [pii] 10.3390/molecules15085336
Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591
Vanhoecke B, Derycke L, Van Marck V, Depypere H, De Keukeleire D, Bracke M (2005) Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int J Cancer 117(6):889–895. doi:10.1002/ijc.21249
Vogel S, Heilmann J (2008) Synthesis, cytotoxicity, and antioxidative activity of minor prenylated chalcones from Humulus lupulus. J Nat Prod 71(7):1237–1241. doi:10.1021/np800188b
Vogel S, Ohmayer S, Brunner G, Heilmann J (2008) Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg Med Chem 16(8):4286–4293. doi: S0968-0896(08)00198-3 [pii] 10.1016/j.bmc.2008.02.079
Vogel S, Barbic M, Jurgenliemk G, Heilmann J (2010) Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Eur J Med Chem 45(6):2206–2213. doi: S0223-5234(10)00105-4 [pii] 10.1016/j.ejmech.2010.01.060
Xuan NT, Shumilina E, Gulbins E, Gu S, Götz F, Lang F (2010) Triggering of dendritic cell apoptosis by xanthohumol. Mol Nutr Food Res 54(S2):S214–S224. doi:10.1002/mnfr.200900324
Yang JY, la-Fera MA, Rayalam S, Baile CA (2007) Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis 12(11):1953–1963
Yang JY, Della-Fera MA, Rayalam S, Baile CA (2008) Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 16(6):1232–1238. doi: oby200866 [pii] 10.1038/oby.2008.66
Zanoli P, Zavatti M (2008) Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol 116(3):383–396
Zhang K, Kaufman RJ (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454(7203):455–462. doi: nature07203 [pii] 10.1038/nature07203
Zhao H, Joseph J, Fales HM, Sokoloski EA, Levine RL, Vasquez-Vivar J, Kalyanaraman B (2005) Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci USA 102(16):5727–5732
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Annex
Annex
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Strathmann, J., Gerhauser, C. (2012). Anti-proliferative and Apoptosis-Inducing Properties of Xanthohumol, a Prenylated Chalcone from Hops (Humulus lupulus L.). In: Diederich, M., Noworyta, K. (eds) Natural compounds as inducers of cell death. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4575-9_4
Download citation
DOI: https://doi.org/10.1007/978-94-007-4575-9_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4574-2
Online ISBN: 978-94-007-4575-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)